Features of phenotyping patients with heart failure with preserved ejection fraction
https://doi.org/10.15829/1560-4071-2023-5348
EDN: ONOGLD
Abstract
The current classification of heart failure (HF) is based on the myocardium systolic function. However, due to the polyetiological nature of the HF with preserved ejection fraction (HFpEF) and its increasing prevalence and clinical significance, a more advanced approach to the clinical assessment of patients is needed to determine the management tactics focused on the patient's phenotype. At the same time, a single algorithm for phenotyping patients with HF has not been formulated yet. There is also no terminological unity in approaches. A review of 47 original articles published in the period from 2015 to 2022 in English on Elsevier, Pubmed, Web of Science databases with a following keywords "HFpEF", "phenotype", "clusters", "phenotypic spectrum", "diastolic dysfunction" makes it possible to identify several different approaches to phenotyping HFpEF, which are based on the etiology, pathophysiological mechanisms or clinical manifestations. Differences in the algorithms used for classification lead to the formation of groups of patients with different characteristics. Today it becomes obvious that in order to develop an optimal phenotyping approach and patient-oriented management of HFpEF, a combined analysis of a large number of anamnestic, clinical and paraclinical data is necessary. To solve such a problem, unified clustering system for HFpEF types should be created, which will be basis for phenotyping patients proposed by the authors.
About the Authors
E. K. SerezhinaRussian Federation
Elena Konstantinovna Serezhina - assistant of hospital therapy department , cardiologist.
St. Petersburg
Competing Interests:
none
A. G. Obrezan
Russian Federation
Andrey Grigorievich Obrezan - professor, chef of hospital therapy department SPbU, chef doctor LLC "MMC".
St. Petersburg
Competing Interests:
none
References
1. Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083.
2. Solomon SD, McMurray JJV, Anand IS, et al. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction. New English Journal of Medicine. 2019;381(17):1609-20. doi:10.1056/NEJMoa1908655.
3. Shah SJ, Katz DH, Selvaraj S, et al. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015;131(3):269-79. doi:10.1161/CIRCULATIONAHA.114.010637.
4. Uijl A, Savarese G, Vaartjes I, et al. Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(6):973-82. doi:10.1002/ejhf.2169.
5. Gu J, Pan JA, Lin H, et al. Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction. International Journal of Cardiology. 2021;323:148-54. doi:10.1016/j.ijcard.2020.08.065.
6. Woolley RJ, Ceelen D, Ouwerkerk W, et al. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. European Journal of Heart Failure. 2021;23(6):983-91. doi:10.1002/ejhf.2144.
7. Casebeer A, Horter L, Hayden J, et al. Phenotypic clustering of heart failure with preserved ejection fraction reveals different rates of hospitalization. J Cardiovasc Med (Hagerstown). 2021;22(1):45-52. doi:10.2459/JCM.0000000000001116.
8. Nouraei H, Rabkin SW. Comparison of Unsupervised Machine Learning Approaches for Cluster Analysis to Define Subgroups of Heart Failure with Preserved Ejection Fraction with Different Outcomes. Bioengineering. 2022;9(4):175. doi:10.3390/bioengineering9040175.
9. Friedman J, Friedman J, Hastie T, et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. Journal of Statistical Software. 2010;33(1):122. doi:10.18637/jss.v033.i01.
Review
For citations:
Serezhina E.K., Obrezan A.G. Features of phenotyping patients with heart failure with preserved ejection fraction. Russian Journal of Cardiology. 2023;28(3S):5348. (In Russ.) https://doi.org/10.15829/1560-4071-2023-5348. EDN: ONOGLD